Cancer

Mission-Driven Research. Life-Changing Results.

Geneva advances mission-driven cancer research that translates discovery into deployable solutions—improving diagnosis, treatment, and survivorship for service members and their families. Embedded within military research sites and leveraging cross-sector collaborations, we accelerate innovation with purpose and precision to strengthen readiness and expand equitable access to care.

 

Why Cancer Research Matters

Cancer poses mission-critical risks to service members, veterans, and their families:

      • Occupational Exposures: Hazardous materials encountered during service increase risks of cancers such as kidney cancer.

      • Lung Cancer Risks: Nearly 900,000 veterans face elevated risks due to smoking, age, and environmental exposures.

      • Operational Exposures: Agent Orange, ionizing radiation, infectious agents, and traumatic brain injury (TBI) further elevate cancer risks in military populations.

      • Readiness Impact: Addressing prevention, diagnosis, treatment, and survivorship gaps is essential to protecting force health and sustaining military readiness.

 

 

The Geneva Advantage

With deep DoD expertise, agile contracting infrastructure, and trusted partnerships, Geneva bridges the gap between innovation and implementation. We accelerate promising cancer research by navigating complex regulatory and operational pathways—delivering mission-ready outcomes that support both military and civilian care.

 

    • Access to Military Assets and Sites: Embedded collaborations with federal labs and military treatment facilities, including the National Cancer Institute, Uniformed Services University, and Madigan Army Medical Center.

    • Proven Performance: Decades of experience advancing cancer research that connects military readiness with patient care, with demonstrated success in securing funding and meeting government requirements.

    • Strategic Innovation: Pioneering projects in biomarker discovery, immunotherapy, and translational medicine—rapidly progressing from bench to battlefield to improve survivorship.

Our Team of Experts

Scientific Publications

Explore the cutting-edge of science with the latest scientific publications from Geneva researchers and thought leaders.

Read Publications